AUSTIN, Texas, July 27 Luminex Corporation (Nasdaq: LMNX), the worldwide leader in multiplexed solutions, today announced the global launch of MAGPIX®, an analytical instrument that is capable of ...

Luminex Corporation (NASDAQ: LMNX) today announced it has received U.S. FDA clearance of its MAGPIX instrument, with its xTAG Gastrointestinal Pathogen Panel (xTAG GPP). This is the first clinical ...

Luminex Corporation (Nasdaq: LMNX), today announced the initial dates and locations for the MAGPIX(R) road show, a multinational tour designed to showcase the recently-launched MAGPIX analytical ...

AUSTIN, Texas, June 1, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX), today announced it has signed a global sales and distribution agreement with Life Technologies Corporation (NASDAQ: LIFE ...

Luminex (NASDAQ:LMNX) receives FDA approval for its MAGPIX instrument with xTAG Gastrointestinal Pathogen Panel. The instrument can perform multiple GI tests in hours, a vast improvement from ...

Diagnostic testing technologies company, Luminex Corporation (LMNX) has won clearance from the U.S. Food and Drug Administration for its MAGPIX instrument, with its xTAG Gastrointestinal Pathogen ...

SANTA CLARA, Calif. & AUSTIN, Texas--(BUSINESS WIRE)--Affymetrix Inc. (NASDAQ: AFFX) and Luminex Corporation (NASDAQ: LMNX) today announced a distribution agreement under which eBioscience, a business ...

Luminex Corporation (Nasdaq: LMNX), the worldwide leader in multiplexed solutions, today announced it has donated the first commercial unit of its newly launched MAGPIX® instrument to Professor Peter ...

Luminex Corporation has announced the global launch of MAGPIX®, an analytical instrument that is capable of performing up to 50 tests on a single sample and providing nearly 5,000 data points in under ...

Diagnostic testing technologies company, Luminex Corporation ( LMNX) has won clearance from the U.S. Food and Drug Administration for its MAGPIX instrument, with its xTAG Gastrointestinal Pathogen ...